Quinoxaline-Based Inhibitors of Malarial Protease PfSUB1*
- 143 Downloads
2,3-Bis(phenylamino)quinoxalines have been identified as a novel class of malarial protease PfSUB1 inhibitors by screening of Malaria Box compounds. The synthesis of analog series and investigation of their inhibitory activity provided preliminary structure–activity relationship to create in silico models for binding of these compounds into the active site of PfSUB1.
Keywordsquinoxaline inhibitors malaria Malaria Box PfSUB1 protease
This work was supported by the EC Marie Curie Initial Training Network “Scientific Training in Antimicrobial Research Strategies” (grant agreement 238490).
The Malaria Box compound collection from Medicines for Malaria Venture foundation is gratefully acknowledged.
- 1.World Malaria Report 2013, World Health Organization, Geneva (2013), http://www.who.int/malaria/media/world_malaria_report_2013/en/
- 12.Medicines for Malaria Venture, http://www.mmv.org/malariabox.
- 14.S. A. Khan, P. Mullick, and H. Manchanda, Indian J. Heterocycl. Chem., 18, 197 (2008).Google Scholar